Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Volume: 357, Issue: 17, Pages: 1695 - 1704
Published: Oct 25, 2007
Abstract
Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF) plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of the head and neck. We compared TPF with PF as induction chemotherapy in patients with locoregionally advanced, unresectable...
Paper Details
Title
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Published Date
Oct 25, 2007
Volume
357
Issue
17
Pages
1695 - 1704
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History